Autoimmune diffuse goiter driven by TSH-receptor stimulating antibodies; most common cause of overt hyperthyroidism.
Also known as: Graves disease, hyperthyroidism, thyrotoxicosis, TSI, diffuse toxic goiter
Overview
Autoimmune hyperthyroidism caused by stimulating antibodies (thyroid-stimulating immunoglobulins, TSI; also called TRAb) that bind and activate the TSH receptor, producing diffuse goiter, sustained thyroid hormone excess, and characteristic extrathyroidal manifestations (orbitopathy, dermopathy).
Epidemiology
Most common cause of hyperthyroidism in the United States. Female-to-male ratio ~5-10:1. Peak onset 30-50 years. Strong familial clustering and association with other autoimmune disease (T1DM, celiac, vitiligo, pernicious anemia, Addison disease).
Try two board-style Hyperthyroidism questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1EndocrineMedium
A 28-year-old woman reports heat intolerance, palpitations, and a 15-lb weight loss. Examination shows exophthalmos and a diffusely enlarged thyroid. Laboratory studies reveal an undetectable TSH, a markedly elevated free T4, and positive thyroid-stimulating immunoglobulin. Which of the following is the most appropriate initial management?
AMethimazole and propranolol
BTotal thyroidectomy
CLevothyroxine replacement
DRadioactive iodine ablation
Reveal answer & full explanation
Correct answer: A — Methimazole and propranolol
AMethimazole and propranolol✓
BTotal thyroidectomy
CLevothyroxine replacement
DRadioactive iodine ablation
Why Methimazole and propranolol is correct
Exophthalmos, diffuse goiter, suppressed TSH, high free T4, and positive thyroid-stimulating immunoglobulin establish Graves disease.
Initial therapy pairs a thionamide (methimazole), which blocks thyroid hormone synthesis, with a beta-blocker (propranolol) for adrenergic symptom control.
Patients are rendered euthyroid before any definitive therapy to avoid precipitating thyroid storm.
Why the others are wrong
Radioactive iodine ablation — a definitive option, but it requires a euthyroid state first and can transiently worsen hyperthyroidism and orbitopathy; choosing it now is right-diagnosis-wrong-step sequencing.
Total thyroidectomy — also definitive, but only after medical stabilization to euthyroid; the same sequencing trap.
Levothyroxine replacement — treats hypothyroidism and would worsen this hyperthyroid patient; an anchoring error on 'thyroid disease equals levothyroxine.'
Question 2EndocrineMedium
A 30-year-old woman at 10 weeks gestation has nausea, palpitations, and a diffusely enlarged thyroid. Free T4 is elevated, TSH is suppressed, and thyroid receptor antibody (TRAb) is positive at 1:320. She has no prior thyroid history. Which of the following antithyroid medications is most appropriate at this stage of pregnancy?
ARadioactive iodine
BPropylthiouracil
CMethimazole
DLevothyroxine
Reveal answer & full explanation
Correct answer: B — Propylthiouracil
ARadioactive iodine
BPropylthiouracil✓
CMethimazole
DLevothyroxine
Why Propylthiouracil is correct
Elevated free T4, suppressed TSH, a diffuse goiter, and a positive TRAb in a 10-week-pregnant patient establish Graves disease as the cause of gestational hyperthyroidism
During the first trimester (organogenesis, roughly weeks 6-10), the American Thyroid Association recommends propylthiouracil (PTU) over methimazole because methimazole is associated with a characteristic embryopathy (aplasia cutis, choanal/esophageal atresia, omphalocele)
Untreated Graves disease in pregnancy raises the risk of fetal loss, preterm delivery, and maternal heart failure, so antithyroid therapy is required rather than observation
Target the free T4 at or just above the upper limit of normal using the lowest effective dose
Why the others are wrong
Radioactive iodine — absolutely contraindicated in pregnancy and lactation because it ablates the fetal thyroid and delivers fetal radiation (confused-with nonpregnant Graves management)
Methimazole — effective but teratogenic during first-trimester organogenesis; it becomes the preferred agent only in the second and third trimesters, when PTU hepatotoxicity outweighs its benefit (right-drug-wrong-trimester)
Levothyroxine — treats hypothyroidism and would worsen this patient's thyrotoxicosis (right-concept-wrong-direction)
Additional high-yield points
Trimester-specific switch: change PTU to methimazole after the first trimester because prolonged PTU use carries rare but serious hepatotoxicity
TRAb crosses the placenta; titers above 3x the upper limit of normal predict fetal/neonatal hyperthyroidism, so monitor fetal heart rate and growth and check neonatal thyroid function at delivery
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Hyperthyroidism (Graves Disease) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Loss of self-tolerance produces IgG antibodies (TRAb/TSI) that bind the TSH receptor and continuously stimulate follicular cells, driving hormone synthesis and gland hyperplasia. The same receptor (or shared antigens) on retro-orbital fibroblasts and pretibial fibroblasts produces orbitopathy and dermopathy. Excess T3/T4 increases beta-adrenergic receptor density and metabolic rate, explaining most clinical features.
TSH-secreting pituitary adenoma — Inappropriately normal/elevated TSH with elevated free T4/T3; pituitary mass on MRI; elevated alpha subunit
Amiodarone-induced thyrotoxicosis — Type 1: iodine-driven excess synthesis (preexisting nodular disease); Type 2: destructive thyroiditis. Color Doppler discriminates
Diagnostic workup
Diagnostic criteria
Suppressed TSH + elevated free T4 and/or T3 + positive TRAb, or diffuse uptake on RAIU scan. Orbitopathy or pretibial myxedema with biochemical thyrotoxicosis is sufficient even without antibody confirmation.
Labs
TSH (suppressed, <0.01 in overt disease) — most sensitive initial test
Free T4 and total T3 (elevated; T3-predominant toxicosis common in Graves)
Pregnancy test in reproductive-age women (alters treatment choice)
Imaging
Radioactive iodine uptake and scan (RAIU/scan) — diffuse, homogeneous, ELEVATED uptake confirms Graves; differentiates from low-uptake thyroiditis and factitious
Thyroid ultrasound with color Doppler — hypervascular (thyroid inferno) in Graves; useful when RAIU contraindicated (pregnancy, lactation, recent iodine)
Orbital CT/MRI without contrast if moderate-to-severe orbitopathy (extraocular muscle enlargement sparing the tendons)
Diagnostic algorithm
Cause
RAIU
Thyroglobulin
TRAb / TSI
Key feature
Graves disease
Elevated, diffuse
Elevated
Positive
Orbitopathy, bruit, diffuse goiter
Toxic multinodular goiter
Patchy, heterogeneous
Elevated
Negative
Older, nodular gland
Toxic adenoma
Focal hot, rest suppressed
Elevated
Negative
Single autonomous nodule
Subacute thyroiditis
Low
Elevated
Negative
Painful, post-viral, elevated ESR
Painless/postpartum thyroiditis
Low
Elevated
Negative
Painless, transient, postpartum
Factitious thyrotoxicosis
Low
LOW
Negative
Exogenous T4 ingestion
Differentiating causes of thyrotoxicosis by RAIU, thyroglobulin, and TRAb.
Treatment
First-line
Beta-blocker for adrenergic symptoms — propranolol 20-40 mg q6h (also blocks peripheral T4→T3 conversion at high dose) or atenolol/metoprolol; use cautiously in HF
Thionamide — methimazole 10-40 mg daily (first-line in non-pregnancy; longer half-life; less hepatotoxicity); propylthiouracil (PTU) preferred in 1st trimester pregnancy and thyroid storm; carbimazole (UK/EU)
Counsel on agranulocytosis (any sore throat or fever → stop drug and check CBC) and hepatotoxicity
Osteoporosis and fracture (especially postmenopausal women)
Severe orbitopathy with vision loss
Thyrotoxic periodic paralysis (Asian male predominance)
Agranulocytosis or hepatotoxicity from thionamides; transient or permanent hypoparathyroidism after surgery
PANCE pearls
TRAb (TSI) is the most specific antibody for Graves disease and helps predict relapse after thionamide withdrawal.
PTU is preferred only in the FIRST trimester of pregnancy and in thyroid storm; methimazole is first-line otherwise because of better hepatic safety.
Avoid radioactive iodine in moderate-to-severe active orbitopathy — it can precipitate flare. Use thyroidectomy or thionamides instead.
Always check beta-hCG before RAI ablation in reproductive-age women.
Thyrotoxic periodic paralysis: sudden hypokalemic paralysis in an Asian man with new hyperthyroidism — treat with potassium and beta-blocker, then definitive thyroid therapy.
References
ATA 2016 — 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (Ross et al., Thyroid 2016)
ATA/AACE Pregnancy 2017 — 2017 Guidelines of the ATA for Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (Alexander et al., Thyroid 2017)
EUGOGO 2021 — The 2021 European Group on Graves' Orbitopathy (EUGOGO) Clinical Practice Guidelines (Bartalena et al., Eur Thyroid J 2021)
Practice Endocrinology questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.